Niva Bupa's Q2 FY26 PAT Doubles to ₹62 Cr; Retail Health GWP Up 24.5% YoY
Niva Bupa's Q2 FY26 PAT more than doubled to ₹62 crore, with Retail Health GWP up 24.5% YoY, reflecting strong operational performance and improved financial health.
Doubling of PAT and strong GWP growth are significant financial achievements that directly impact investor perception and the company's valuation. Improved solvency and claims ratio also signal strong operational health.
The company reported significant growth in PAT (more than double), strong GWP growth, improved combined ratio, and a robust solvency ratio, indicating strong financial and operational performance. Management commentary is also positive.
* Niva Bupa Health Insurance reported strong financial results for Q2 FY26 and H1 FY26, ended September 30, 2025. * Profit After Tax (IFRS) more than doubled to ₹62 crore in Q2 FY26, up from ₹24 crore in Q2 FY25. * Retail Health Gross Written Premium (GWP) increased by 24.5% year-on-year. * Overall GWP for Q2 FY26 stood at ₹2,108 crore (without 1/n basis) and ₹1,843 crore (with 1/n basis). * For H1 FY26, the company recorded GWP of ₹3,983 crore (without 1/n) and ₹3,475 crore (with 1/n). * The Combined Insurance Service Ratio (IFRS) improved by 141 basis points to 103.1% in Q2 FY26. * The company maintained a strong Claims Settlement Ratio of 95.2% and an improved Solvency Ratio of 2.85x, well above regulatory requirements. * Customer advocacy score (NPS) was 57, and the company now covers 23.14 million (2.314 crore) lives. * MD & CEO Krishnan Ramachandran highlighted disciplined execution, sustained retail health growth, and improved quality of business metrics, attributing the enhanced Claims Settlement Ratio to data science-led underwriting. He also noted positive consumer sentiment post GST exemption. * Distribution channels in Q2 FY26 were led by Individual Agency (31%), followed by Brokers (27%), Bancassurance (20%), Direct business (10%), and Corporate Agents (11%), with the latter showing the fastest growth of 44% YoY.
What to do with a filing like this
Niva Bupa Health Insurance Company Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Niva Bupa Health Insurance Company Limited. Read the original for the full detail.